하이드록시아파타이트 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Hydroxyapatite Market Size, Share & Trends Analysis Report By Product (Nano Sized, Micro Sized), By End-use (Dental Care, Plastic Surgery, Orthopedics), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,530,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,964,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,831,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

하이드록시아파타이트 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 하이드록시아파타이트 시장 규모는 2030년까지 39억 2,000만 달러에 달하며 예측 기간 동안 CAGR 7.5%를 나타낼 것으로 예측됩니다. 하이드록시아파타이트 시장은 그 생체적합성과 골전도 특성에 의해 골이식편, 치과용 코팅, 정형외과용 임플란트에서 널리 사용되고 있는 것이 원동력이 되고 있습니다.

2024년 예측 기간에는 나노사이즈 부문이 58.3%의 수익 점유율을 차지하고 시장을 독점했습니다. 나노사이즈 부문은 강화된 생물활성, 고표면적, 우수한 골전도 특성으로 성장 오리, 뼈 이식편, 치과용 코팅, 약물전달 시스템 등의 생물 의료 용도에 이상적입니다.

2024년 예측기간에서는 정형외과 부문이 56.3%의 수익 점유율로 시장을 독점했습니다. 골다공증, 관절염, 골절 증가, 특히 고령화 사회 증가가 수요를 촉진하고 있습니다.

예측 기간 중 2024년 시장 점유율은 아시아태평양이 50.7%로 시장을 독점했습니다. 중국, 일본, 인도 등의 국가들은 의료 진보에 투자하고 있으며, 재생 의료 및 생체 재료에 있어서의 하이드록시아파타이트의 용도를 뒷받침하고 있습니다.

하이드록시아파타이트 시장의 유력 기업은 APS Materials Inc., Zimmer Biomet, Bio-Rad Laboratories Inc., CGbio, Fluidinova, The Lubrizol Corporation, Granulab Sdn. Bhd., SigmaGraft Biomaterials, Berkeley Advanced Biomaterials(GNI Group Ltd), Taihei Chemica Industrial Co. Ltd 입니다.

하이드록시아파타이트 시장 보고서 하이라이트

• 뛰어난 생체적합성, 고표면적, 강화된 생물활성에 의해 정형외과, 치과, 약물전달 용도에 이상적이기 때문에 나노 사이즈 부문은 2024년에 58.3%의 최대 수익 점유율을 차지했습니다.
• 아시아태평양은 수산화알루미늄 시장의 지배적인 지역이며 2024년의 수익 점유율은 50.7%였습니다. 아시아 태평양 수산화인회석 시장은 치약, 스킨케어 등 수산화인회석을 함유한 퍼스널 케어 제품에 대한 소비자 인식이 높아지면서 시장 성장을 뒷받침하고 있습니다. 그러나 규제 문제와 원자재 비용 변동이 시장 확대에 영향을 미칠 수 있습니다.
• 2023년 5월 정형외과용 임플란트 제조체이자 의료기기회사인 HAPPE Spine은 자사 제품 중 하나인 INTEGRATE-C Interbody Fusion System이 FDA로부터 510(k) 허가를 취득했다고 발표했습니다. 이 시스템은 수술 중 및 수술 후 영상 진단을 향상시키기 위해 방사선 투과성과 방사선 가시성을 의도하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

• 세계의 하이드록시아파타이트 시장 전망
• 밸류체인 분석
  • 원료의 전망
  • 정형외과/제품 전망
  • 유통 채널 분석
• 가격 동향 분석
  • 가격에 영향을 미치는 요인
• 규제 프레임워크
  • 표준 및 규정 준수
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 과제 분석
  • 시장 기회 분석
• Porter's Five Forces 분석
  • 공급기업의 협상력
  • 구매자의 협상력
  • 대체 위협
  • 신규 참가업체의 위협
  • 경쟁 기업간 경쟁 관계
• PESTLE 분석
  • 정치
  • 경제
  • 사회
  • 제품
  • 환경
  • 법률

제4장 하이드록시아파타이트 시장 : 제품별, 추정·동향 분석

• 하이드록시아파타이트 시장 : 제품 변동 분석(2023년, 2030년)
• 나노 사이즈
• 마이크로 사이즈
• 마이크로미터 이상

제5장 하이드록시아파타이트 시장 : 최종 용도별, 추정·동향 분석

• 하이드록시아파타이트 시장 : 최종 용도 변동 분석(2023년, 2030년)
• 치과 치료
• 성형외과
• 정형외과
• 기타

제6장 하이드록시아파타이트 시장 : 지역별, 추정·동향 분석

• 지역 분석(2023년, 2030년)
• 북미
  • 제품별(2018-2030년)
  • 최종 용도별(2018-2030년)
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 제품별(2018-2030년)
  • 최종 용도별(2018-2030년)
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
• 아시아태평양
  • 제품별(2018-2030년)
  • 최종 용도별(2018-2030년)
  • 중국
  • 인도
  • 일본
  • 한국
• 라틴아메리카
  • 제품별(2018-2030년)
  • 최종 용도별(2018-2030년)
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 제품별(2018-2030년)
  • 최종 용도별(2018-2030년)
  • 사우디아라비아
  • 남아프리카

제7장 경쟁 구도

• 주요 시장 진출기업의 최근 동향
• 기업 분류
• 기업 히트맵 분석
• 기업의 시장 포지셔닝 분석(2024년)
• 전략 매핑
• 기업 프로파일/상장 기업
  • APS Materials Inc.
  • Zimmer Biomet
  • Emeron Electric Co.
  • CGbio
  • Argana Group
  • The Lubrizol Corporation
  • Granulab Sdn. Bhd.
  • SigmaGraft Biomaterials
  • Berkeley Advanced Biomaterials(GNI Group Ltd)
  • Zimmer Biomet
  • Taihei Chemica Industrial Co. Ltd.

KTH

영문 목차

영문목차

Hydroxyapatite Market Growth & Trends:

The global hydroxyapatite market size is anticipated to reach USD 3.92 billion by 2030 and is anticipated to expand at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The hydroxyapatite market is driven by its wide use in bone grafts, dental coatings, and orthopedic implants due to its biocompatibility and osteoconductive properties. The increasing prevalence of osteoporosis, arthritis, and tooth loss, particularly among aging populations, is driving demand.

The nano-sized segment dominated the market with a revenue share of 58.3% in 2024, during the forecast period. The nano-sized segment is growing due to its enhanced bioactivity, high surface area, and superior osteoconductive properties, making it ideal for biomedical applications such as bone grafts, dental coatings, and drug delivery systems. Increasing demand in regenerative medicine, orthopedics, and personal care products is driving market expansion.

The orthopedics segment dominated the market with a revenue share of 56.3% in 2024, during the forecast period. The orthopedics segment is expected to grow as product market is widely used in bone grafts, implants, and coatings for joint replacements due to its biocompatibility and osteoconductive properties. Rising cases of osteoporosis, arthritis, and bone fractures, particularly among aging populations, are fueling demand. Advancements in 3D printing and regenerative medicine are further enhancing hydroxyapatite's role in orthopedic applications.

Asia Pacific dominated the market with a market share of 50.7% in 2024, during the forecast period. The Asia Pacific market is expanding due to increasing demand in orthopedic and dental implants, driven by a rising aging population and improved healthcare infrastructure. Countries such as China, Japan, and India are investing in medical advancements, boosting hydroxyapatite applications in regenerative medicine and biomaterials.

Some of the prominent players in the cryogenic gases market include APS Materials Inc., Zimmer Biomet, Bio-Rad Laboratories Inc., CGbio, Fluidinova, The Lubrizol Corporation, Granulab Sdn. Bhd., SigmaGraft Biomaterials, Berkeley Advanced Biomaterials (GNI Group Ltd), and Taihei Chemica Industrial Co. Ltd.

Hydroxyapatite Market Report Highlights:

• The nano-sized segment is expected to have the largest revenue share of 58.3% in 2024. due to its superior biocompatibility, high surface area, and enhanced bioactivity, making it ideal for orthopedic, dental, and drug delivery applications. Advancements in nanotechnology and biomedical research are driving demand, particularly in bone regeneration and implant coatings.
• Asia Pacific is the dominant region for the aluminum hydroxide market with a revenue share of 50.7% in 2024. The Asia Pacific hydroxyapatite market is growing due to growing consumer awareness of personal care products incorporating hydroxyapatite, such as toothpaste and skincare, is further supporting market growth. However, regulatory challenges and fluctuating raw material costs may impact market expansion.
• In May 2023, HAPPE Spine, an orthopedic implants manufacturer, and medical device company, announced that one of its products, INTEGRATE-C Interbody Fusion System, got 510(k) clearance from the FDA. This system is the first interbody fusion cage fully integrated with hydroxyapatite and designed with porosity, promoting bone ingrowth and enhancing cell signaling. It is intended to be radiolucent and radiovisible, enhancing imaging during and after surgery. The significance of this advancement is that the system offers various sizes and angles to suit different patient anatomies.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Information Analysis
  • 1.3.2. Market Formulation & Data Visualization
  • 1.3.3. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Global Hydroxyapatite Market Outlook
• 3.2. Value Chain Analysis
  • 3.2.1. Raw Material Outlook
  • 3.2.2. Plastic Surgery/Product Outlook
  • 3.2.3. Sales Channel Analysis
• 3.3. Price Trend Analysis
  • 3.3.1. Factors Influencing Prices
• 3.4. Regulatory Framework
  • 3.4.1. Standards & Compliances
• 3.5. Market Dynamics
  • 3.5.1. Market Driver Analysis
  • 3.5.2. Market Restraint Analysis
  • 3.5.3. Market Challenges Analysis
  • 3.5.4. Market Opportunity Analysis
• 3.6. Porter's Five Forces Analysis
  • 3.6.1. Bargaining Power of Suppliers
  • 3.6.2. Bargaining Power of Buyers
  • 3.6.3. Threat of Substitution
  • 3.6.4. Threat of New Entrants
  • 3.6.5. Competitive Rivalry
• 3.7. PESTLE Analysis
  • 3.7.1. Political
  • 3.7.2. Economic
  • 3.7.3. Social Landscape
  • 3.7.4. Product
  • 3.7.5. Environmental
  • 3.7.6. Legal

Chapter 4. Hydroxyapatite Market: Product Estimates & Trend Analysis

• 4.1. Hydroxyapatite Market: Product Movement Analysis, 2023 & 2030
• 4.2. Nano-sized
  • 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 4.3. Micro-sized
  • 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 4.4. Greater than Micrometers
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Hydroxyapatite Market: End Use Estimates & Trend Analysis

• 5.1. Hydroxyapatite Market: End Use Movement Analysis, 2023 & 2030
• 5.2. Dental Care
  • 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.3. Plastic Surgery
  • 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.4. Orthopedics
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
• 5.5. Other End Uses
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Hydroxyapatite Market: Regional Estimates & Trend Analysis

• 6.1. Regional Analysis, 2023 & 2030
• 6.2. North America
  • 6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.2.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • 6.2.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.2.4. U.S.
    • 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.2.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.2.5. Canada
    • 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.2.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.2.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.2.6. Mexico
    • 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.2.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.2.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
• 6.3. Europe
  • 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.3.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • 6.3.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.3.4. Germany
    • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.3.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.3.5. UK
    • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.3.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.3.6. France
    • 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.3.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.3.7. Italy
    • 6.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.3.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.3.8. Spain
    • 6.3.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.3.8.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
• 6.4. Asia Pacific
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • 6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.4.4. China
    • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.4.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.4.5. India
    • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.4.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.4.6. Japan
    • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.4.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.4.7. South Korea
    • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.4.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
• 6.5. Latin America
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • 6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.5.4. Brazil
    • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.5.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.5.5. Argentina
    • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.5.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
• 6.6. Middle East & Africa
  • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
  • 6.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.6.4. Saudi Arabia
    • 6.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)
  • 6.6.5. South Africa
    • 6.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Billion)
    • 6.6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Market Positioning Analysis, 2024
• 7.5. Strategy Mapping
• 7.6. Company Profiles/Listing
  • 7.6.1. APS Materials Inc.
    • 7.6.1.1. Company Overview
    • 7.6.1.2. Financial Performance
    • 7.6.1.3. Product Benchmarking
  • 7.6.2. Zimmer Biomet
    • 7.6.2.1. Company Overview
    • 7.6.2.2. Financial Performance
    • 7.6.2.3. Product Benchmarking
  • 7.6.3. Emeron Electric Co.
    • 7.6.3.1. Company Overview
    • 7.6.3.2. Financial Performance
    • 7.6.3.3. Product Benchmarking
  • 7.6.4. CGbio
    • 7.6.4.1. Company Overview
    • 7.6.4.2. Financial Performance
    • 7.6.4.3. Product Benchmarking
  • 7.6.5. Argana Group
    • 7.6.5.1. Company Overview
    • 7.6.5.2. Financial Performance
    • 7.6.5.3. Product Benchmarking
  • 7.6.6. The Lubrizol Corporation
    • 7.6.6.1. Company Overview
    • 7.6.6.2. Financial Performance
    • 7.6.6.3. Product Benchmarking
  • 7.6.7. Granulab Sdn. Bhd.
    • 7.6.7.1. Company Overview
    • 7.6.7.2. Financial Performance
    • 7.6.7.3. Product Benchmarking
  • 7.6.8. SigmaGraft Biomaterials
    • 7.6.8.1. Company Overview
    • 7.6.8.2. Financial Performance
    • 7.6.8.3. Product Benchmarking
  • 7.6.9. Berkeley Advanced Biomaterials (GNI Group Ltd)
    • 7.6.9.1. Company Overview
    • 7.6.9.2. Financial Performance
    • 7.6.9.3. Product Benchmarking
  • 7.6.10. Zimmer Biomet
    • 7.6.10.1. Company Overview
    • 7.6.10.2. Financial Performance
    • 7.6.10.3. Product Benchmarking
  • 7.6.11. Taihei Chemica Industrial Co. Ltd.
    • 7.6.11.1. Company Overview
    • 7.6.11.2. Financial Performance
    • 7.6.11.3. Product Benchmarking

관련자료